This Article Abstract Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Gurm, H. S. Articles by Topol, E. J. Search for Related Content PubMed PubMed Citation Articles by Gurm, H. S. Articles by Topol, E. J.

Outcome of acute ST-segment elevation myocardial infarction in diabetics treated with fibrinolytic or combination reduced fibrinolytic therapy and platelet glycoprotein IIb/IIIa inhibition

Lessons from the GUSTO V trial

Hitinder S. Gurm, MD^*, A. Michael Lincoff, MD^*,*, David Lee, MD^*, W. H. Wilson Tang, MD^*, Gang Jia, MS^*, Joan E. Booth, RN^*, Robert M. Califf, MD, E. M. Ohman, MD, Frans Van de Werf, MD, PhD, Paul W. Armstrong, MD^||, Victor Guetta, MD^¶, Robert Wilcox, MD^# and Eric J. Topol, MD^*

^* Cleveland Clinic Foundation, Cleveland, Ohio, USA
Duke Clinical Research Institute, Durham, North Carolina, USA
The University of North Carolina at Chapel Hill, North Carolina, USA
University Hospital Gasthuisberg, Leuven, Belgium
^|| University of Alberta, Edmonton, Canada
^¶ The Chaim Sheba Medical Center, Tel-Hashomer, Israel
^# University Hospital Nottingham, Nottingham, United Kingdom

View larger version (17K): [in a new window]   Figure 1 Outcome of diabetics with myocardial infarction randomized to standard versus combination therapy. CABG = coronary artery bypass grafting; CI = confidence interval; PCI = percutaneous coronary intervention.